Skip to main content
MedPathMedPath Home
Clinical Trials/IRCT20200825048515N58
IRCT20200825048515N58
Recruiting
Phase 3

Evaluation of therapeutic effects of adding memantine to stimulants in children with attention deficit hyperactivity disorder

Esfahan University of Medical Sciences0 sites80 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
Esfahan University of Medical Sciences
Enrollment
80
Status
Recruiting
Last Updated
3 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • •Children with attention deficit hyperactivity disorder (ADHD)
  • •Age range 6 to 12 years
  • •Treated with methylphenidate
  • •Parents' consent to participate in the study

Exclusion Criteria

  • •Having major medical disorders (diabetes, asthma, heart disease, seizures)
  • •Having a concomitant psychiatric disorder (mood and anxiety disorders and behavioral and confrontational disorders \- disobedience)
  • •Taking another drug in addition to a long\-acting stimulant
  • •Mental retardation
  • •Drug sensitivity

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Phase 3
Assessment the effect of memantine in the treatment of chemotherapy-induced peripheral neuropathychemotherapy-induced peripheral neuropathy in patients with cancer.Idiopathic peripheral autonomic neuropathyG90.0
IRCT20160310026998N12Tabriz University of Medical Sciences180
Completed
Phase 2
The efficacy of complementory use of memantine in treatment of schizophrenia with chronic courseSchizophrenia.Schizophrenia
IRCT201306015605N1Clinical psychiatry research center, Tabriz university of medical sciences60
Not yet recruiting
Phase 3
The effectiveness of the combination of Memantine and Betahistine on insomnia severity, quality of life and severity of symptoms in people with primary tinnitus
IRCT20190427043389N4Zanjan University of Medical Sciences60
Completed
Phase 2
Memantine effect in the treatment of residual symptoms in patients with schizophrenia
IRCT2017013032236N2Vice chancellor for research, Mazandaran University of Medical Sciences50
Completed
Not Applicable
A study on the effect of memantine for psychological symptoms and cerebral blood flow of patients with Alzheimer's disease.Alzheimer&#39s disease
JPRN-UMIN000010794Katsushika Medical Center, The Jikei University School of Medicine20